RVXCF — Stock activity · TradeandTellRVXC
RVXCF
$0.08+$0.00 (+6.37%)prev close
Held by
0
portfolios on TandT
Avg position size
—
of holders' portfolios
52-week range
$0.05 – $0.10
54% from low
Held by traders on TradeandTell
No one on the platform currently holds RVXCF.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in RVXCF as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded RVXCF yet.
Insider activity (SEC Form 4)
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Analyst estimates (consensus)
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|
| 2026 | $0 | -100.0% | $-0.13 | $-0.13–$-0.13 | — | 1 |
| 2027 | $0 | — | $-0.16 | $-0.16–$-0.16 | — | 1 |
| 2028 | $0 | — | $-0.57 | $-0.57–$-0.57 | — | 1 |
| 2029 | $15M | — | $-0.30 | $-0.30–$-0.30 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Earnings surprises
Beat consensus in 5 of the last 5 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|
| 2026-05-19 | $-0.08 | $-0.01 | +85.4% |
| 2025-11-13 | $-0.08 | $-0.00 | +95.9% |
| 2025-08-14 | $-0.08 | $-0.01 | +87.1% |
| 2025-06-04 | $-0.08 | $-0.02 | +78.2% |
| 2025-03-28 | $-0.08 | $0.00 | +102.1% |
Peer comparison
| Symbol | Price | Today | Mkt cap | P/E |
|---|
| RVXCFResverlogix Corp. | $0.08 | +14.29% | $25M | — |
| BBIXFBonus Biogroup Ltd. | $0.08 | +0.00% | $93M | — |
| CLCSCell Source, Inc. | $0.60 | -0.88% | $41M | — |
| CLYYFCelyad Oncology S.A. | $0.28 | +0.00% | $13M | — |
| CWBHFCharlotte's Web Holdings, Inc. | $0.30 | +1.03% |
| ELVAFEvolva Holding S.A. | $2.15 | +0.00% | $16M | — |
| FNCHFinch Therapeutics Group, Inc. | $10.20 | +0.99% | $16M | — |
Source: Financial Modeling Prep · peers by sector/industry